Varenismart 1 mg Healing Pharma

£46.00

Varenismart 1 mg Healing Pharma provides laboratory-grade varenicline for tobacco cessation research studies. This pharmaceutical-quality compound supports investigations into nicotinic acetylcholine receptor modulation and smoking behaviour analysis in controlled research environments.

 

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
Varenismart 1 mg Healing Pharma
Varenismart 1 mg Healing Pharma
£46.00

[wpforms id=”1190″ title=”true” description=”Request a call back”]

About Varenismart

Varenismart 1 mg is a pharmaceutical-grade varenicline formulation manufactured by Healing Pharma for laboratory research applications. Varenicline is a selective nicotinic receptor partial agonist that has demonstrated significant utility in tobacco cessation research studies. This compound operates through dual mechanisms of action, functioning as both a partial agonist at α4β2 nicotinic acetylcholine receptors and an antagonist that blocks nicotine binding sites. Research teams investigating smoking cessation pathways, nicotinic receptor pharmacology, and addiction neuroscience rely on high-purity varenicline to conduct meaningful studies. The 1 mg tablet formulation provides researchers with standardised dosing for experimental protocols examining nicotinic receptor modulation.

Laboratory Applications

Researchers utilise varenicline in diverse experimental contexts including neuropharmacology studies, receptor binding assays, and behavioural analysis protocols. The compound’s unique pharmacological profile makes it valuable for investigating nicotine dependence mechanisms and withdrawal syndrome research. Scientists at Stroid UK Shop frequently order varenicline alongside other research chemicals from our varenicline category for comprehensive addiction research programmes. Laboratory studies examining α4β2 receptor subtypes, dopaminergic pathway interactions, and smoking cessation efficacy models benefit from varenicline’s well-characterised pharmacokinetic profile. Research teams also investigate this compound’s potential applications beyond tobacco cessation, including studies on cognitive function and neuroplasticity. Many laboratories complement their varenicline research with compounds from our SARMs collection or peptide research chemicals for comprehensive experimental designs.

Product Specifications

Varenismart 1 mg Technical Data
Parameter Specification
Active Ingredient Varenicline
Dosage Strength 1 mg per tablet
Manufacturer Healing Pharma
CAS Number 249296-44-4
Molecular Formula C₁₃H₁₃N₃
Molecular Weight 211.26 g/mol
Storage Requirements Room temperature, dry conditions
Research Applications Tobacco cessation, nicotinic receptor studies

Research Compliance

Varenismart 1 mg Healing Pharma is manufactured exclusively for in-vitro laboratory research and analytical testing purposes. This product is not intended for human consumption, therapeutic use, or any diagnostic applications. Researchers must ensure proper laboratory protocols, safety measures, and regulatory compliance when handling this research chemical. All experimental procedures should follow institutional guidelines and appropriate research ethics standards for pharmaceutical compound investigations.

Related